Award
Eunice Kennedy Shriver National Institute of Child Health and Human Development 5R01HD113612-03
Continuous glucose monitoring for management of type 2 diabetes in pregnancy (CGM2 trial)
Recipient
National Institute of Child Health and Human Development (NICHD), Eunice Kennedy Shriver National Institute of Child Health and Human Development
Award Amount
$752,645.00
Ceiling
$752,645.00
Awarded
July 28, 2026
Identifier
5R01HD113612-03
Award for a multicenter randomized controlled trial to evaluate continuous glucose monitoring in pregnant women with type 2 diabetes, aiming to improve maternal and neonatal health outcomes.
Description
This project aims to evaluate the effectiveness of real-time continuous glucose monitoring (CGM) in pregnant women with type 2 diabetes mellitus (T2DM). The study will compare CGM to standard blood glucose self-monitoring (SMBG) across multiple aims, including reducing neonatal morbidity and mortality, improving maternal glycemic control, and identifying social, biological, and ecological factors affecting outcomes. The study involves a multicenter, open-label randomized controlled trial with 564 participants, and is funded by NICHD with an award amount of $752,645. The project is part of a broader effort to improve maternal and child health outcomes in disadvantaged populations.